Flyer: Introducing Eurofins Beacon Discovery; the GPCR experts
Learn how you can partner for success with Eurofins Beacon Discovery’s industry leading GPCR experts to support your program from concept to clinic.
Eurofins Beacon Discovery is an industry leader in GPCR drug discovery offering an integrated approach for challenging GPCR targets. The Beacon Team has identified in excess of 30 pre-clinical candidates of which more than 20 programs have moved successfully into clinical development. Beacon Discovery employs an integrated workflow that will fully support your discovery program. Learn how you can take advantage of Eurofins Beacon Discovery’s capabilities now!
Related content from this organisation
- Decoding cancer and inflammation: identifying selective inhibitors of SH2 domains
- Comprehensive in vitro approach to evaluate transporter-mediated drug interactions in drug discovery
- Leveraging the E3scanTM technology platform for next-generation targeted protein degradation
- Human iPSC-derived cardiomyocytes for cardiac proarrhythmic risk assessment
- Flyer: Introducing Eurofins Beacon Discovery; the GPCR experts